These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 21746763)

  • 41. Substrate specificity of heparanases from human hepatoma and platelets.
    Pikas DS; Li JP; Vlodavsky I; Lindahl U
    J Biol Chem; 1998 Jul; 273(30):18770-7. PubMed ID: 9668050
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis.
    Vlodavsky I; Friedmann Y; Elkin M; Aingorn H; Atzmon R; Ishai-Michaeli R; Bitan M; Pappo O; Peretz T; Michal I; Spector L; Pecker I
    Nat Med; 1999 Jul; 5(7):793-802. PubMed ID: 10395325
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modulations of glypican-1 heparan sulfate structure by inhibition of endogenous polyamine synthesis. Mapping of spermine-binding sites and heparanase, heparin lyase, and nitric oxide/nitrite cleavage sites.
    Ding K; Sandgren S; Mani K; Belting M; Fransson LA
    J Biol Chem; 2001 Dec; 276(50):46779-91. PubMed ID: 11577085
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulating Heparanase Activity: Tuning Sulfation Pattern and Glycosidic Linkage of Oligosaccharides.
    Zhu S; Li J; Loka RS; Song Z; Vlodavsky I; Zhang K; Nguyen HM
    J Med Chem; 2020 Apr; 63(8):4227-4255. PubMed ID: 32216347
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Computational Investigation Identified Potential Chemical Scaffolds for Heparanase as Anticancer Therapeutics.
    Parate S; Kumar V; Danishuddin ; Hong JC; Lee KW
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34156395
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Specificity and action pattern of heparanase Bp, a β-glucuronidase from Burkholderia pseudomallei.
    Yu Y; Williams A; Zhang X; Fu L; Xia K; Xu Y; Zhang F; Liu J; Koffas M; Linhardt RJ
    Glycobiology; 2019 Jul; 29(8):572-581. PubMed ID: 31143933
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Processing of macromolecular heparin by heparanase.
    Gong F; Jemth P; Escobar Galvis ML; Vlodavsky I; Horner A; Lindahl U; Li JP
    J Biol Chem; 2003 Sep; 278(37):35152-8. PubMed ID: 12837765
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes.
    Hoogewerf AJ; Leone JW; Reardon IM; Howe WJ; Asa D; Heinrikson RL; Ledbetter SR
    J Biol Chem; 1995 Feb; 270(7):3268-77. PubMed ID: 7852412
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular Aspects of Heparanase Interaction with Heparan Sulfate, Heparin and Glycol Split Heparin.
    Elli S; Guerrini M
    Adv Exp Med Biol; 2020; 1221():169-188. PubMed ID: 32274710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Deciphering mode of action of heparanase using structurally defined oligosaccharides.
    Peterson S; Liu J
    J Biol Chem; 2012 Oct; 287(41):34836-43. PubMed ID: 22893710
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A liquid chromatography-mass spectrometry-based approach to characterize the substrate specificity of mammalian heparanase.
    Mao Y; Huang Y; Buczek-Thomas JA; Ethen CM; Nugent MA; Wu ZL; Zaia J
    J Biol Chem; 2014 Dec; 289(49):34141-51. PubMed ID: 25336655
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of active-site residues of the pro-metastatic endoglycosidase heparanase.
    Hulett MD; Hornby JR; Ohms SJ; Zuegg J; Freeman C; Gready JE; Parish CR
    Biochemistry; 2000 Dec; 39(51):15659-67. PubMed ID: 11123890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heparanase: Historical Aspects and Future Perspectives.
    Khanna M; Parish CR
    Adv Exp Med Biol; 2020; 1221():71-96. PubMed ID: 32274707
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The sulfate-binding site structure of the human eosinophil cationic protein as revealed by a new crystal form.
    Boix E; Pulido D; Moussaoui M; Nogués MV; Russi S
    J Struct Biol; 2012 Jul; 179(1):1-9. PubMed ID: 22579681
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemically modified heparins as inhibitors of heparan sulfate specific endo-beta-glucuronidase (heparanase) of metastatic melanoma cells.
    Irimura T; Nakajima M; Nicolson GL
    Biochemistry; 1986 Sep; 25(18):5322-8. PubMed ID: 3768351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human heparanase. Purification, characterization, cloning, and expression.
    Toyoshima M; Nakajima M
    J Biol Chem; 1999 Aug; 274(34):24153-60. PubMed ID: 10446189
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular properties and involvement of heparanase in cancer progression and normal development.
    Vlodavsky I; Goldshmidt O; Zcharia E; Metzger S; Chajek-Shaul T; Atzmon R; Guatta-Rangini Z; Friedmann Y
    Biochimie; 2001 Aug; 83(8):831-9. PubMed ID: 11530216
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.
    Barash U; Cohen-Kaplan V; Dowek I; Sanderson RD; Ilan N; Vlodavsky I
    FEBS J; 2010 Oct; 277(19):3890-903. PubMed ID: 20840586
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human heparanase nuclear localization and enzymatic activity.
    Schubert SY; Ilan N; Shushy M; Ben-Izhak O; Vlodavsky I; Goldshmidt O
    Lab Invest; 2004 May; 84(5):535-44. PubMed ID: 15034597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heparanase - Discovery and Targets.
    Lindahl U; Li JP
    Adv Exp Med Biol; 2020; 1221():61-69. PubMed ID: 32274706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.